1. Genes (Basel). 2016 Sep 19;7(9):66. doi: 10.3390/genes7090066.

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype.

Amorim JP(1)(2)(3), Santos G(4)(5)(6), Vinagre J(7)(8)(9), Soares 
P(10)(11)(12)(13).

Author information:
(1)Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 
Porto 4200-135, Portugal. jamorim@ipatimup.pt.
(2)Instituto de Patologia e Imunologia Molecular da Universidade do Porto 
(Ipatimup), Porto 4200-135, Portugal. jamorim@ipatimup.pt.
(3)Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto 
4050-313, Portugal. jamorim@ipatimup.pt.
(4)Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 
Porto 4200-135, Portugal. gsantos@ipatimup.pt.
(5)Instituto de Patologia e Imunologia Molecular da Universidade do Porto 
(Ipatimup), Porto 4200-135, Portugal. gsantos@ipatimup.pt.
(6)Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto 
4050-313, Portugal. gsantos@ipatimup.pt.
(7)Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 
Porto 4200-135, Portugal. jvinagre@ipatimup.pt.
(8)Instituto de Patologia e Imunologia Molecular da Universidade do Porto 
(Ipatimup), Porto 4200-135, Portugal. jvinagre@ipatimup.pt.
(9)Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto 
4050-313, Portugal. jvinagre@ipatimup.pt.
(10)Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 
Porto 4200-135, Portugal. psoares@ipatimup.pt.
(11)Instituto de Patologia e Imunologia Molecular da Universidade do Porto 
(Ipatimup), Porto 4200-135, Portugal. psoares@ipatimup.pt.
(12)Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, 
Porto 4050-313, Portugal. psoares@ipatimup.pt.
(13)Departamento de Patologia e Oncologia, Faculdade de Medicina da Universidade 
do Porto, Porto 4200-139, Portugal. psoares@ipatimup.pt.

Telomeres are responsible for protecting chromosome ends in order to prevent the 
loss of coding DNA. Their maintenance is required for achieving immortality by 
neoplastic cells and can occur by upregulation of the telomerase enzyme or 
through a homologous recombination-associated process, the alternative 
lengthening of telomeres (ALT). The precise mechanisms that govern the 
activation of ALT or telomerase in tumor cells are not fully understood, 
although cellular origin may favor one of the other mechanisms that have been 
found thus far in mutual exclusivity. Specific mutational events influence ALT 
activation and maintenance: a unifying frequent feature of tumors that acquire 
this phenotype are the recurrent mutations of the Alpha Thalassemia/Mental 
Retardation Syndrome X-Linked (ATRX) or Death-Domain Associated Protein (DAXX) 
genes. This review summarizes the established criteria about this phenotype: its 
prevalence, theoretical molecular mechanisms and relation with ATRX, DAXX and 
other proteins (directly or indirectly interacting and resulting in the ALT 
phenotype).

DOI: 10.3390/genes7090066
PMCID: PMC5042396
PMID: 27657132

Conflict of interest statement: The authors declare no conflict of interest.